The Immunobuddies
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Buddies with an interest in the area of immunotherapy and its development. We simply discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.
Also on
Recent episodes
- Episode 227: When Two Organs Flare Up Is It One Process with Dr Tom Clarke
- Episode 226: When Immunotherapy Meets A Transplanted Organ
- Episode 225: A Skin Cancer Meeting In Madrid With Drinks
- Episode 224: How To Design A Clinical Pathway For T-Cell Engager Bispecifics
- Episode 223: HLH: When Ferritin Hits The Stratosphere And Everyone Panics
- Episode 222: Cytokine Release Syndrome Basics
- Episode 221: Immunotherapy Toxicity In Early Triple Negative Breast Cancer - Toxicity vs Efficacy With Dr Olubukola Ayodele
- Episode 220: Why Triple Negative Breast Cancer Responds to Immunotherapy With Dr Olubukola Ayodele
- Episode 219: Time of Day Impact on Immunotherapy Outcomes - Next Steps Final Part Dr Alfred So (On behalf of NOTCH)
- Episode 218: Time of Day Impact on Immunotherapy Outcomes - Conflicting Data Part 3 Dr Alfred So (On behalf of NOTCH)